China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$3.02 +0.21 (+7.30%)
As of: Sep 30, 2026 · 12:09 PM EDT

China SXT Pharmaceuticals (SXTC) Capital Expenditures (2017 - 2019)

Updated

China SXT Pharmaceuticals' Capital Expenditures was -$2,023 in FY2025 (year ended Mar 31, 2025), compared with -$7,063 in FY2024.

Analysis

China SXT Pharmaceuticals (SXTC) Capital Expenditures (2017 - 2019) Analysis & Trends

From FY2017 onward, China SXT Pharmaceuticals has reported Capital Expenditures for 9 fiscal years.

  • The FY2025 figure marks the highest annual Capital Expenditures since FY2020.
  • Per Business Quant data, Capital Expenditures in earlier fiscal years was -$7,063 in FY2024, -$70,684 in FY2023, -$60,932 in FY2022 and -$78,302 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 China SXT Pharmaceuticals 33,069.96 -85.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -535,825.00
Dec 31, 2018 -436,017.00
Dec 31, 2017 -179,176.00
API Access

China SXT Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SXTC&period=max&api_key=YOUR_API_KEY